Decrease in Intracellular Perforin Levels and IFN-γ Production in Human CD8+ T Cell Line following Long-Term Exposure to Asbestos Fibers
暂无分享,去创建一个
H. Matsuzaki | T. Otsuki | Y. Nishimura | Suni Lee | K. Yoshitome | N. Kumagai-Takei | N. Kumagai-takei
[1] W. Hager,et al. and s , 2019, Shallow Water Hydraulics.
[2] Takemi Otsuki,et al. Functional Properties of CD8+ Lymphocytes in Patients with Pleural Plaque and Malignant Mesothelioma , 2014, Journal of immunology research.
[3] H. Matsuzaki,et al. Effect of asbestos exposure on differentiation of cytotoxic T lymphocytes in mixed lymphocyte reaction of human peripheral blood mononuclear cells. , 2013, American journal of respiratory cell and molecular biology.
[4] W. Marsden. I and J , 2012 .
[5] T. Otsuki,et al. Decreased CXCR3 expression in CD4+ T cells exposed to asbestos or derived from asbestos-exposed patients. , 2011, American journal of respiratory cell and molecular biology.
[6] T. Otsuki,et al. Reduction of CXC chemokine receptor 3 in an in vitro model of continuous exposure to asbestos in a human T-cell line, MT-2. , 2011, American journal of respiratory cell and molecular biology.
[7] T. Nakano,et al. Impairment in Cytotoxicity and Expression of NK Cell- Activating Receptors on Human NK Cells following Exposure to Asbestos Fibers , 2009, International journal of immunopathology and pharmacology.
[8] J. Lieberman,et al. Death by a thousand cuts: granzyme pathways of programmed cell death. , 2008, Annual review of immunology.
[9] G. Sancini,et al. Translocation pathways for inhaled asbestos fibers , 2008, Environmental health : a global access science source.
[10] C. Hack,et al. Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation. , 2007, Molecular immunology.
[11] R. Flavell,et al. JNK2 negatively regulates CD8+ T cell effector function and anti‐tumor immune response , 2007, European journal of immunology.
[12] A. Rao,et al. Chromosome transfer activates and delineates a locus control region for perforin. , 2007, Immunity.
[13] Robert D. Schreiber,et al. Interferons, immunity and cancer immunoediting , 2006, Nature Reviews Immunology.
[14] J. Virchow,et al. Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma. , 2006, Blood.
[15] V. Maino,et al. Ex vivo analysis of T-cell function. , 2005, Current opinion in immunology.
[16] A. Palucka,et al. Dendritic cells as therapeutic vaccines against cancer , 2005, Nature Reviews Immunology.
[17] S. Kyrtopoulos,et al. Mutagenesis by asbestos in the lung of λ-lacI transgenic rats , 2004 .
[18] A. Collins,et al. Genotoxic effects of asbestos in humans. , 2004, Mutation research.
[19] P. Henkart,et al. Perforin and the granule exocytosis cytotoxicity pathway. , 2003, Current opinion in immunology.
[20] T. Ley,et al. Lymphocyte-mediated cytotoxicity. , 2003, Annual review of immunology.
[21] F. Brière,et al. Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. , 2002, Blood.
[22] M. Takiguchi,et al. Differentiation of Human CD8+ T Cells from a Memory to Memory/Effector Phenotype1 , 2002, The Journal of Immunology.
[23] R. Dodson,et al. Asbestos content in the lymph nodes of nonoccupationally exposed individuals. , 2000, American journal of industrial medicine.
[24] M. Rep,et al. Phenotypic and Functional Separation of Memory and Effector Human CD8+ T Cells , 1997, The Journal of experimental medicine.
[25] G. Guthrie,et al. Mineral properties and their contributions to particle toxicity. , 1997, Environmental health perspectives.
[26] A. Morgan. Acid leaching studies of chrysotile asbestos from mines in the Coalinga region of California and from Quebec and British Columbia. , 1997, The Annals of occupational hygiene.
[27] M. Klein,et al. Phenotypic and functional separation of memory and effector human CD 8 + T cells , 1997 .
[28] Y. Shinohara,et al. Mineral phases and some reexamined characteristics of the International Union Against Cancer standard asbestos samples. , 1996, American journal of industrial medicine.
[29] S. Weitzman,et al. Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers. , 1996, Cancer investigation.
[30] H. Weill,et al. Mesothelioma , 1995, The Lancet.
[31] H. Asada,et al. Establishment and characterization of the T-cell line, EBT-8 latently infected with Epstein-Barr virus from large granular lymphocyte leukemia. , 1994, Leukemia.
[32] C. Bianchi,et al. A Comparison of Asbestos Burden in Lung Parenchyma, Lymph Nodes, and Plaques , 1991, Annals of the New York Academy of Sciences.
[33] F. Balkwill. INTERFERONS , 1989, The Lancet.
[34] R. Herberman,et al. Lymphocyte-mediated cytotoxicity. , 1987, Pediatric annals.
[35] M. Stanton,et al. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. , 1981, Journal of the National Cancer Institute.
[36] E. C. Hammond,et al. Latency of asbestos disease among insulation workers in the United States and Canada , 1980, Cancer.
[37] E. C. Hammond,et al. MORTALITY EXPERIENCE OF INSULATION WORKERS IN THE UNITED STATES AND CANADA, 1943‐1976 * , 1979, Annals of the New York Academy of Sciences.
[38] A. D. McDonald,et al. Mesothelioma after crocidolite exposure during gas mask manufacture. , 1978, Environmental research.